ADMA Biologics (ADMA) PT Raised to $10 at Maxim Group
Tweet Send to a Friend
Maxim Group raised its price target on ADMA Biologics (NASDAQ: ADMA) to $10.00 (from $8.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
